The Effect of Behavior Exchange Program on Risky Behaviors

August 6, 2024 updated by: Gülşah KÖRPE, Istanbul Medipol University Hospital

The Effect of Transtheoretical Model Based Behavior Exchange Program on Risky Behaviors of University Students Receiving Health Education

Risky behaviors, which derive their source from features specific to adolescence, may also pose problems in other periods of a person's life and have features that prevent them from becoming responsible adults. These behaviors are defined by Jessor as behaviors that cause personal, social or developmental undesirable consequences and are life-threatening or harmful to health and even actions that can lead to death. Risky behaviors in young people are frequently listed as smoking, alcohol/substance use, nutrition, suicide, school dropout, and destructive behaviors (violence against self/others, etc.). It has been conducted with studies that generally do not take into account the stage of change or accept that all individuals' readiness for behavior change is the same. However, the Transtheoretic Model states that the most appropriate initiatives should be used to facilitate the change in which the individual is at the stage of change. He also states that the initiatives applied without considering the individual's readiness for behavior change develop resistance against behavior change. In this study, it was aimed to determine the effect of the behavior change program prepared based on the transtheoretic model on the risky behaviors of university students receiving health education.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Type of Research This study was planned as a randomized controlled experimental study to determine the effect of the Transtheoretical Model-Based Behavior Change Program applied to university students on the tendency to show risky behavior.

The Universe and Place of the Research The general population of the research will consist of students enrolled in the formal education program at Istanbul Medipol University Faculty of Health Sciences between September 2020 and February 2021. Volunteer students who have Turkish literacy skills, are over 18 years old, do not have major-active psychiatric disease, have a high Risk Behavior Scale-University Form score, and are in the Thinking and Preparation phase of change.

2.3. Sample of the Research Sample size was calculated by power analysis. In the calculation made; Predicting a power value of 0.80 and a level of error of 0.05, it was found that the Risk Behaviors Scale-University Form should be administered to at least 348 people from the general population in order to reach the study population. In the calculation made, it was found appropriate to include 40 students in the experimental group and 40 students in the control group. Assignment will be made to the experimental and control groups by making a probabilistic selection from the study universe. One of participants in the experimental group left the study. The study was completed with 79 participants in total.

Variables of the Study

Independent variables

  • Transtheoretic model-based behavior change program
  • Group consultancy
  • Motivational interview

Dependent Variables

  • Risky Behaviors Scale-University Form score average
  • Behavior Change Stages Short Questionnaire result
  • Self-Efficacy-Efficacy Scale mean score

Research Steps

  1. In order to identify the risky students in the study population, the University Form of the Risk Behaviors Scale will be applied to the students of the Faculty of Health Sciences.
  2. Students with a high score as a result of the Risk Behaviors Scale-University Form will be determined.
  3. The Behavior Change Stages Short Questionnaire will be applied to students with a high risky behavior tendency.
  4. Students whose behavior change stages are determined as 'Thinking' and 'Preparation' will be included in the study universe.
  5. Assignment will be made to the experimental and control groups by making a random selection from the study universe.
  6. The Self-Efficacy-Efficacy Scale will be applied to the experimental and control groups.
  7. Transtheoretic Model Based Behavior Change Program (Annex-1) will be applied to the experimental group. The behavior change program includes group counseling and motivational interviews. Short training will be given to the control group to reduce risky behaviors after the study.
  8. All measurements of the experimental and control groups will be repeated after the program and 3 months after the end of the program.
  9. The data will be statistically analyzed and evaluated.
  10. The report will be written.

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Beykoz
      • Istanbul, Beykoz, Turkey, 34810
        • Istanbul Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Getting a high score on the Risk Behavior Modification-University Form scale
  • Stages of change being Thinking or Preparation,
  • Being over the age of 18,
  • Not having major-active psychiatric disease,
  • Having Turkish literacy skills

Exclusion Criteria:

  • students who do not meet the inclusion criteria
  • who refused to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group

As a pre-test, 40 students, who were determined in accordance with the research criteria and assigned to the experimental group, were asked to fill in the Sociodemographic data collection form and SCEÖ.

Before the planned program, students were sent an e-mail and the program days and times were specified. 4 groups of 10 people were formed. Transtheoretic Model Based Behavior Change Program consisting of 7 sessions was given. At the end of the program, the Risky Behavior Evaluation Scale, which was included in the RSS-ÜF, Behavior Change Stages Short Questionnaire, SEYÖ and Soyodemographic data collection form, was applied again. Follow-up was done with the same measurement tools 3 months after the end of the program.
Behavioral: Transtheoretic Model Based Behavior Change Program
The Behavior Change Program was implemented in 7 sessions of 50 minutes, once a week. Each session in the Behavior Change Program; The warm-up exercise consisted of giving general information about the purpose and the main theme of the session, discussion and feedback on the subject, and the planning of the next week, and a closing process. The Transtheoretic Model Based Behavior Change Program was prepared by the researcher with reference to the behavior change programs in the literature and the elements of the Transtheoretic model.
No Intervention: Control Group

As a pre-test, 40 students who were determined in accordance with the research criteria and assigned to the control group were asked to fill in the Sociodemographic data collection form and SCEÖ. For the posttest and 3-month follow-up, the Risky Behavior Evaluation Scale, which was included in the RSS-ÜF, Behavior Change Stages Short Question Form, SEEÖ and Soyodemographic data collection form, was applied again.

After the Transtheoretical Model-Based Behavior Change Program given to the experimental group ended, a 1-day training program on changing risky behaviors was applied to the control group in September 2021. All students in the experimental group participated in the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risky behaviors scale-university form
Time Frame: 1 year

The scale consists of 60 items and sevendimensions such as; antisocial behaviors, smoking, alcohol use, substance use, suicide tendency, eating habitsand school dropout.

RDÖUF (RBS-UF) is a Likert-type scale consisting of 60 items and seven dimensions. The five-point scale is answered as "always= 5", "usually= 4", "sometimes= 3", "rarely=2" and "never=1". There is no reverse scored item in the scale. Getting a high score on each dimension indicates a higher level of risk in that dimension.
1 year
self-efficacy scale
Time Frame: 1 year
For each item on the 23-item scale; 1-" drink what I don't know", 2-"describes me a little", 3-"I'm undecided", 4-" me best defines me", S-"describes me very well" is requested. The score given for each item is taken as a basis. But 2,4,5,6,7, 10, 11, 12,14,16,17,18,20,22. items are scored in the opposite direction. So from the scale a minimum of 23 and a maximum of 115 points can be obtained.The increase in the total score obtained from the scale, the individual's self-efficacy-efficacy It means that the perception is at a good level.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Medipol University Hospital

Collaborators

Medipol University

Investigators

  • Study Chair: Leyla KÜÇÜK, 2, Istanbul Cerrahpaşa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2020

Primary Completion (Actual)

April 15, 2021

Study Completion (Actual)

July 15, 2021

Study Registration Dates

First Submitted

February 22, 2022

First Submitted That Met QC Criteria

August 6, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 6, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GUL121312

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

I can share privately if desired.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe